Warner Pharmaceutical (688799.SH) obtained the drug registration certificate for Iguratimod Tablets.

Zhitong Finance APP News, Warner Pharmaceutical (688799.SH) announced that recently, the company received the "Drug Registration Certificate" for Iguratimod Tablets approved and issued by the National Medical Products Administration. Iguratimod Tablets are used to treat active rheumatoid arthritis. The company's Iguratimod Tablets obtained the drug registration certificate under the new registration classification of Category 4 chemical drugs, and are deemed to have passed the consistency evaluation.